Oct-06-20 Initiated
Northland Capital
Market Perform
$225
Sep-11-20 Initiated
Wolfe Research
Peer Perform
$230
Apr-13-20 Downgrade
Barclays
Equal Weight → Underweight
$155
Apr-01-20 Downgrade
Goldman
Buy → Sell
$248 → $150
Mar-05-20 Initiated
Citigroup
Buy
$235
Feb-13-20 Initiated
Goldman
Buy
$248
Jan-08-20 Initiated
SunTrust
Hold
$217
Jan-07-20 Downgrade
Piper Sandler
Overweight → Neutral
$210
Jan-07-20 Downgrade
Piper Jaffray
Overweight → Neutral
$210
Dec-30-19 Reiterated
BTIG Research
Buy
$228 → $236
Nov-05-19 Downgrade
Barclays
Overweight → Equal Weight
$226 → $207
Oct-30-19 Reiterated
BofA/Merrill
Buy
$220 → $245
Jul-02-19 Downgrade
Evercore ISI
Outperform → In-line
Jan-30-19 Reiterated
Canaccord Genuity
Buy
$185 → $190
Jan-03-19 Initiated
Deutsche Bank
Buy
$179
Jan-02-19 Upgrade
Evercore ISI
In-line → Outperform
Oct-16-18 Initiated
Barclays
Overweight
$198
Aug-16-18 Initiated
BTIG Research
Buy
$187
Jun-27-18 Initiated
Bernstein
Mkt Perform
$177
Apr-27-18 Reiterated
Stifel
Buy
$183 → $187
Jan-26-21 10:23AM
Jan-22-21 09:50AM
Jan-12-21 08:03AM
Jan-08-21 10:16AM
Jan-07-21 01:17PM
11:49AM
Jan-06-21 06:28AM
Jan-05-21 10:22AM
09:22AM
09:17AM
08:00AM
06:57AM
Jan-04-21 02:00PM
Dec-22-20 11:48AM
Dec-18-20 04:39PM
Dec-17-20 03:53AM
Dec-16-20 06:30AM
Dec-14-20 03:12PM
Dec-13-20 10:35PM
Dec-04-20 03:50PM
Dec-02-20 04:49PM
04:05PM
Nov-25-20 09:56AM
Nov-18-20 05:00PM
Nov-17-20 09:30AM
Nov-16-20 03:57PM
11:02AM
Nov-13-20 09:24AM
Nov-11-20 07:45AM Investor's Business Daily
07:45AM
Nov-10-20 09:15PM
09:31AM
Nov-09-20 12:52PM
07:30AM
Nov-04-20 07:30AM
Nov-03-20 11:53AM
Nov-02-20 02:45PM
02:12PM
Oct-30-20 10:40AM
Oct-29-20 05:25PM
04:46PM
04:05PM
02:30PM
Oct-28-20 09:53AM
Oct-26-20 07:54AM
07:48AM
07:30AM
Oct-22-20 12:33PM
Oct-21-20 07:35AM
Oct-15-20 12:10PM
Oct-14-20 06:16AM
Oct-13-20 07:30AM
05:42AM
Oct-07-20 08:54AM
Oct-05-20 08:42AM
Oct-02-20 04:12PM
04:12PM
Sep-29-20 07:30AM
Sep-28-20 02:00PM
06:38AM
Sep-15-20 08:00PM
Sep-10-20 06:10PM
Sep-02-20 01:00PM
Aug-31-20 10:10PM
Aug-29-20 11:32AM
Aug-28-20 07:30AM
Aug-20-20 10:21AM
Aug-14-20 09:03AM
Jul-31-20 12:58PM
08:34AM
Jul-30-20 05:45PM
04:05PM
08:00AM
Jul-29-20 09:16AM
Jul-27-20 10:36AM
Jul-23-20 12:33PM
Jul-09-20 06:22AM
Jul-06-20 09:03PM
Jul-03-20 12:10PM
08:11AM
Jun-29-20 07:30AM
Jun-25-20 10:14AM
09:30AM
Jun-23-20 09:46PM Thomson Reuters StreetEvents
Jun-17-20 01:47PM
Jun-11-20 10:18PM
11:05AM
Jun-09-20 06:51AM
Jun-05-20 07:58AM Investor's Business Daily Video
Jun-01-20 03:01AM
May-30-20 11:31AM
May-29-20 11:58AM
May-27-20 03:40PM
May-26-20 05:45PM
04:15PM
May-20-20 10:18AM
May-14-20 05:28PM
11:07AM
May-13-20 01:05PM
May-06-20 06:35AM
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Boehnlein Glenn S VP, Chief Financial Officer Dec 28 Sale 239.10 2,000 478,209 14,321 Dec 29 02:19 PM Lobo Kevin Chairman and CEO Dec 07 Option Exercise 53.60 27,985 1,499,996 98,376 Dec 09 01:20 PM Lobo Kevin Chairman and CEO Dec 07 Sale 236.28 10,697 2,527,534 70,391 Dec 09 01:20 PM Scannell Timothy J President and COO Nov 23 Option Exercise 60.20 98,590 5,934,945 258,954 Nov 24 10:08 AM Scannell Timothy J President and COO Nov 23 Sale 232.61 5,000 1,163,038 213,598 Nov 24 10:08 AM Berry William E Jr VP, Corporate Controller Nov 13 Sale 231.84 1,275 295,597 314 Nov 17 03:00 PM Datar Srikant M. Director Oct 13 Option Exercise 53.60 1,945 104,252 20,290 Oct 14 09:58 AM Datar Srikant M. Director Sep 17 Option Exercise 53.60 3,000 160,800 19,091 Sep 18 03:49 PM STRYKER RONDA E Director Aug 06 Sale 186.14 140,000 26,059,442 0 Aug 10 02:40 PM Scannell Timothy J President and COO Aug 01 Option Exercise 0.00 3,659 0 184,759 Aug 04 03:28 PM Doliveux Roch Director Jul 31 Buy 191.94 53 10,173 22,070 Aug 03 05:45 PM Lobo Kevin Chairman and CEO Jul 31 Sale 190.80 25,855 4,933,046 70,349 Aug 03 05:38 PM Lobo Kevin Chairman and CEO Jul 30 Option Exercise 58.02 25,855 1,500,107 96,204 Aug 03 05:38 PM Boehnlein Glenn S VP, Chief Financial Officer Jun 15 Sale 185.24 10,351 1,917,375 16,321 Jun 17 03:24 PM Golston Allan C. Director May 29 Option Exercise 59.09 10,465 618,387 18,135 Jun 02 05:39 PM Golston Allan C. Director May 29 Sale 193.23 7,299 1,410,386 9,027 Jun 02 05:39 PM Datar Srikant M. Director May 20 Sale 191.25 400 76,500 16,091 May 22 07:32 PM Datar Srikant M. Director May 19 Option Exercise 59.70 1,235 73,730 17,226 May 22 07:32 PM Datar Srikant M. Director May 19 Sale 191.20 350 66,920 16,491 May 22 07:32 PM Datar Srikant M. Director May 08 Sale 194.32 200 38,864 15,991 May 08 06:59 PM Datar Srikant M. Director May 07 Sale 189.99 500 94,995 16,191 May 08 06:59 PM Owen Katherine Ann VP, Strategy and IR May 07 Sale 190.81 3,121 595,504 1,085 May 08 05:09 PM Owen Katherine Ann VP, Strategy and IR May 06 Option Exercise 106.66 12,983 1,384,804 8,642 May 08 05:09 PM Datar Srikant M. Director May 06 Option Exercise 59.70 2,500 149,250 17,686 May 08 06:59 PM Datar Srikant M. Director May 06 Sale 186.01 200 37,202 16,691 May 08 06:59 PM Owen Katherine Ann VP, Strategy and IR May 05 Sale 186.79 9,149 1,708,910 1,085 May 07 09:18 PM Doliveux Roch Director May 01 Option Exercise 0.00 937 0 22,017 May 04 08:25 PM Menon Viju Group President May 01 Option Exercise 0.00 3,443 0 5,622 May 05 09:35 PM Suri Rajeev Director May 01 Option Exercise 0.00 937 0 1,985 May 05 09:19 PM STRYKER RONDA E Director May 01 Option Exercise 0.00 937 0 86,932 May 05 09:05 PM FRANCESCONI LOUISE Director May 01 Option Exercise 0.00 937 0 17,583 May 05 08:25 PM Datar Srikant M. Director May 01 Option Exercise 0.00 937 0 15,186 May 05 08:19 PM BRAINERD MARY K Director May 01 Option Exercise 0.00 937 0 2,585 May 05 08:13 PM Fletcher Robert S VP, Chief Legal Officer Apr 30 Option Exercise 0.00 4,272 0 4,272 Apr 30 08:14 PM Doliveux Roch Director Apr 30 Buy 190.09 51 9,694 21,080 May 04 08:25 PM Berry William E Jr VP, Corporate Controller Mar 21 Option Exercise 0.00 1,325 0 1,694 Mar 24 03:53 PM Datar Srikant M. Director Mar 04 Option Exercise 59.70 1,000 59,700 14,249 Mar 06 12:52 PM Scannell Timothy J President and COO Feb 24 Option Exercise 59.70 34,555 2,062,934 190,105 Feb 25 05:19 PM Doliveux Roch Director Feb 06 Option Exercise 57.32 6,781 388,703 26,796 Feb 10 03:39 PM Doliveux Roch Director Feb 06 Sale 217.87 3,540 771,258 21,029 Feb 10 03:39 PM STRYKER RONDA E Director Feb 03 Option Exercise 53.09 9,995 530,635 85,995 Feb 05 09:57 AM FRANCESCONI LOUISE Director Jan 31 Option Exercise 53.09 9,995 530,635 26,641 Feb 05 09:04 AM Doliveux Roch Director Jan 31 Buy 216.67 45 9,750 20,912 Feb 04 09:59 PM FRANCESCONI LOUISE Director Jan 31 Sale 213.65 7,513 1,605,163 16,646 Feb 05 09:04 AM Datar Srikant M. Director Jan 29 Option Exercise 53.09 4,395 233,331 14,339 Jan 31 03:53 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite